Non-surgical myocardial reduction in hypertrophic obstructive cardiomyopathy

Israel Medical Association Journal

Volumn 4, Issue 2, 2002, Pages 86-90

  Mutlak, Diab ^a   Gruberg, Luis ^a   Reisner, Shimon ^a   Markiewicz, Walter ^a  

^a RAMBAM MEDICAL CENTER   (Israel)

Author keywords

Ablation; Alcohol; Balloon; Cardiomyopathy; Catheterization; Myocardial infarction

Indexed keywords

CARDIOVASCULAR SURGERY; HEMODYNAMICS; PATIENT TREATMENT;

MYOCARDIAL REDUCTION;

BIOMEDICAL ENGINEERING;

MIDAZOLAM; MORPHINE; PROPAFENONE;

ADULT; AGED; ANGINA PECTORIS; ARTICLE; ATRIOVENTRICULAR BLOCK; BALLOON CATHETER; CATHETER ABLATION; CLINICAL ARTICLE; COMPLETE HEART BLOCK; DEATH; DOPPLER ECHOGRAPHY; DYSPNEA; FEMALE; FOLLOW UP; HEART ATRIUM FIBRILLATION; HEART HEMODYNAMICS; HEART INFARCTION; HEART LEFT VENTRICLE OUTFLOW TRACT; HEART PACING; HEART RIGHT BUNDLE BRANCH BLOCK; HEART VENTRICLE FIBRILLATION; HUMAN; HYPERTROPHIC OBSTRUCTIVE CARDIOMYOPATHY; LEFT ANTERIOR DESCENDING CORONARY ARTERY; LONG TERM CARE; MALE; MEDICAL SOCIETY; MITRAL VALVE REGURGITATION; PAIN; REST; SYMPTOMATOLOGY; VALSALVA MANEUVER;

ADULT; AGED; ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; CARDIOMYOPATHY, HYPERTROPHIC; CATHETER ABLATION; ECHOCARDIOGRAPHY, DOPPLER; FEMALE; HEMODYNAMIC PROCESSES; HUMANS; MALE; MIDDLE AGED; TIME FACTORS; TREATMENT OUTCOME; VENTRICULAR OUTFLOW OBSTRUCTION; VENTRICULAR REMODELING;

EID: 0036185553     PISSN: 15651088     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (19)

1. Prevalence of hypertrophic cardiomyopathy in a general population of young adults: Echocardiographic analysis of 4111 subjects in the CARDIA study
2. Hypertrophic cardiomyopathy
3. Hypertrophic cardiomyopathy-continued progress
4. Hypertrophic cardiomyopathy
5. Hypertrophic cardiomyopathy
6. Heterogenous morphologic expression of genetically transmitted hypertrophic cardiomyopathy: Two-dimensional echocardiographic analysis
7. Morphologic determinants of echocardiographic patterns of mitral valve systolic anterior motion in obstructive hypertrophic cardiomyopathy
8. The management of hypertrophic cardiomyopathy
9. Therapeutic options in patients with obstructive hypertrophic cardiomyopathy and severe drug-refractory symptoms
10. Non-surgical myocardial reduction for hypertrophic obstructive cardiomyopathy
11. Non-surgical septal reduction for hypertrophic obstructive cardiomyopathy: Outcome in the first series of patients
12. Percutaneous transluminal septal myocardial ablation in hypertrophic obstructive cardiomyopathy: Acute results and 3-months follow-up in 25 patients
13. Acute and long-term results after transcoronary ablation of septal hypertrophy (TASH)
14. Echocardiographic-guided ethanol septal reduction for hypertrophic obstructive cardiomyopathy
15. Left ventricular outflow tract gradient decrease with non-surgical myocardial reduction improves exercise capacity in patients with hypertrophic obstructive cardiomyopathy
16. Percutaneous transluminal septal myocardial ablation: A new treatment for hypertrophic obstructive cardiomyopathy
17. Induced septal infarction. A new therapeutic strategy for hypertrophic obstructive cardiomyopathy
18. Recommendations regarding quantification in M-Mode echocardiography: Results of a survey of echocardiographic measurements
19. Alcohol septal ablation in hypertrophic obstructive cardiomyopathy: The need for a registry